Literature DB >> 21274079

Lung cancer: to treat or not to treat?

M Goldberg.   

Abstract

Surgical resection is the best form of treatment for primary non-small cell lung cancer. In resected cases the overall five year survival rate is 35%. The prognosis depends on cell type, nodal status and tumor size. Palliation of symptoms can be controlled in most instances by chemotherapy, radiation therapy or a combination of both. Presently there is no proven role for adjuvant irradiation therapy and chemotherapy after curative resection. Small cell carcinoma should be treated with combination chemotherapy and prophylactic cranial radiation; these therapies prolong survival and control symptoms. Patients' questions should be answered specifically and in no greater depth than the patient desires. Close communication should be maintained between physician, patient and a designated member of the family.

Entities:  

Year:  1985        PMID: 21274079      PMCID: PMC2327551     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  10 in total

Review 1.  Current concepts in cancer: small-cell lung cancer.

Authors:  F A Greco; R K Oldham
Journal:  N Engl J Med       Date:  1979-08-16       Impact factor: 91.245

2.  Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes.

Authors:  T Naruke; K Suemasu; S Ishikawa
Journal:  J Thorac Cardiovasc Surg       Date:  1976-02       Impact factor: 5.209

3.  Treatment of Superior Sulcus Tumor by Irradiation Followed by Resection.

Authors:  R R Shaw; D L Paulson; J L Kee
Journal:  Ann Surg       Date:  1961-07       Impact factor: 12.969

4.  Comparison of treatment policies in inoperable bronchial carcinoma.

Authors:  K R Durrant; R J Berry; F Ellis; F R Ridehalgh; J M Black; W S Hamilton
Journal:  Lancet       Date:  1971-04-10       Impact factor: 79.321

5.  The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.

Authors:  B Roswit; M E Patno; R Rapp; A Veinbergs; B Feder; J Stuhlbarg; C B Reid
Journal:  Radiology       Date:  1968-04       Impact factor: 11.105

6.  Combined modality treatment of small cell carcinoma of the lung.

Authors:  R Feld; J F Pringle; W K Evans; C W Keen; I C Quirt; J E Curtis; M A Baker; J L Yeoh; G Deboer; T C Brown
Journal:  Arch Intern Med       Date:  1981-03

7.  Small cell carcinoma of the lung.

Authors:  R B Livingston
Journal:  Blood       Date:  1980-10       Impact factor: 22.113

8.  Commentary: current status of chemotherapy for non-small cell lung cancer.

Authors:  J Aisner; H H Hansen
Journal:  Cancer Treat Rep       Date:  1981 Nov-Dec

9.  Segmental resection for bronchogenic carcinoma.

Authors:  R J Jensik; L P Faber; C F Kittle
Journal:  Ann Thorac Surg       Date:  1979-11       Impact factor: 4.330

10.  A twenty-year analysis of the results of sleeve resection for primary bronchogenic carcinoma.

Authors:  W F Bennett; R A Smith
Journal:  J Thorac Cardiovasc Surg       Date:  1978-12       Impact factor: 5.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.